Alpine Global Management’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-19,555
Closed -$44.2K 264
2024
Q2
$44.2K Buy
+19,555
New +$44.2K 0.01% 445
2019
Q2
Sell
-19,093
Closed -$98K 81
2019
Q1
$98K Sell
19,093
-4,258
-18% -$21.9K 0.03% 86
2018
Q4
$80K Buy
+23,351
New +$80K 0.02% 215
2015
Q3
Sell
-13,681
Closed -$37K 371
2015
Q2
$37K Buy
+13,681
New +$37K 0.01% 844